-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

801.O1.6 801. Gene Therapies: The Long and the Short of Clinical Trials in Blood Disorders

Symposia: Gene Therapies Program: Oral and Poster Abstracts
Type: Oral
Monday, December 11, 2023: 4:30 PM-6:00 PM
Hall A (San Diego Convention Center)
Moderators:
Kyle Cromer, PhD, MPhil, BS, and Alexis Kristine Leonard, MD,
Disclosures:
Leonard: bluebird bio: Consultancy; Vertex Pharmaceuticals: Consultancy.
4:30 PM

Julie Kanter, MD1, Alexis A. Thompson, MD, MPH2,3, Janet L. Kwiatkowski, MD, MSCE2,4, Suhag Parikh, MD5*, Markus Mapara, MD6, Stacey Rifkin-Zenenberg, DO7, Banu Aygun, MD8,9, Kimberly A. Kasow, DO10*, Ashish O. Gupta, MBBS, MPH11, Lixin Zhang, PhD12*, Emily Sheldon-Waniga, PhD12*, Meghan Gallagher, MSc12*, Katiana Gruppioni, MPH12*, Anjulika Chawla, MD, FAAP12, Heidi Elliot12*, Francis J. Pierciey, MSc12*, Mark C. Walters, MD13 and John F. Tisdale, MD14

1Division of Hematology and Oncology, University of Alabama, Birmingham, AL
2Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, PA
4Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
5Cellular Therapies for Nonmalignant Diseases Clinic, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
6Blood and Marrow Stem Cell Transplantation Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York, NY
7Pediatric Hematology/Oncology Division, Hackensack University Medical Center, Hackensack, NJ
8Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY
9Division of Pediatric Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center, New Hyde Park, NY
10University of North Carolina, Chapel Hill, NC
11Division of Pediatric Blood and Marrow Transplant and Cellular Therapies, University of Minnesota, Minneapolis, MN
12bluebird bio, Inc., Somerville, MA
13UCSF Benioff Children's Hospital, Oakland, CA
14Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD

4:45 PM

Haydar Frangoul, MD1, Franco Locatelli, MD, PhD2, Akshay Sharma, MBBS3, Monica Bhatia, MD4*, Markus Mapara, MD5, Lyndsay Molinari, MD6, Donna Wall, MD7, Robert I. Liem, MD8, Paul Telfer, MD9*, Ami J. Shah, MD10, Marina Cavazzana, MD, PhD11, Selim Corbacioglu, MD, PhD12*, Damiano Rondelli, MD13*, Roland Meisel, MD14*, Laurence Dedeken, MD15, Stephan Lobitz, MSc16*, Mariane de Montalembert, MD, PhD17, Martin H. Steinberg, MD18, Mark C. Walters, MD19, Laura Bower, MD20*, Suzan Imren, MD20*, Christopher Simard, MD20*, Fengjuan Xuan, PhD20*, Weiyu Zhou, PhD20*, Phuong Khanh Morrow, MD21*, William Hobbs, MD, PhD20 and Stephan Grupp, MD, PhD22

1Sarah Cannon Research Institute at The Children’s Hospital at TriStar Centennial, Nashville, TN
2IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy
3St. Jude Children's Research Hospital, Memphis, TN
4Department of Pediatrics, Columbia University Irving Medical Center, New York – Presbyterian-Morgan Stanley Children’s Hospital, New York, NY
5Division of Hematology and Oncology, Columbia University, New York, NY
6Sarah Cannon Pediatric Transplant and Cellular Therapy Program at Methodist Children’s Hospital, San Antonio, TX
7SickKids, Toronto, Canada
8Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
9Royal London Hospital, Barts Health NHS Trust, London, United Kingdom
10Center for Definitive and Curative Medicine, Stanford University, Palo Alto, CA
11Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris, Paris, France
12University of Regensburg, Regensburg, Germany
13Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
14Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
15Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium
16Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany
17Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), University of Paris-Cité, Paris, France
18Boston University Chobanian & Avedisian School of Medicine, Boston, MA
19UCSF Benioff Children's Hospital, Oakland, CA
20Vertex Pharmaceuticals, Boston, MA
21CRISPR Therapeutics, Cambridge, MA
22Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

5:00 PM

Franco Locatelli, MD, PhD1, Peter Lang, MD, PhD2*, Selim Corbacioglu, MD, PhD3*, Donna Wall, MD4, Roland Meisel, MD5*, Amanda M Li, MD6, Josu de La Fuente, PhD7, Ami J. Shah, MD8, Ben Carpenter, MD, PhD9*, Janet L. Kwiatkowski, MD, MSCE10, Markus Mapara, MD11, Robert I. Liem, MD12, Maria Domenica Cappellini, MD13, Mattia Algeri, MD1*, Antonis Kattamis, MD, PhD14, Sujit Sheth, MD15, Stephan Grupp, MD, PhD16, Puja Kohli, MD, MMSc17*, Daoyuan Shi, PhD17*, Leorah Ross, MD, PhD17*, Yael Bobruff, PhD17*, Christopher Simard, MD17*, Lanju Zhang, PhD17*, Phuong Khanh Morrow, MD18*, William Hobbs, MD, PhD17 and Haydar Frangoul, MD19

1IRCCS, Ospedale Pediatrico Bambino Gesù Rome, Catholic University of the Sacred Heart, Rome, Italy
2University of Tübingen, Tübingen, Germany
3University of Regensburg, Regensburg, Germany
4The Hospital for Sick Children/University of Toronto, Toronto, Canada
5Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Duesseldorf, Germany
6BC Children’s Hospital, University of British Columbia, Vancouver, Canada
7Imperial College Healthcare NHS Trust, St Mary's Hospital, London, United Kingdom
8Center for Definitive and Curative Medicine, Stanford University, Palo Alto, CA
9University College London Hospitals NHS Foundation Trust, London, United Kingdom
10Children’s Hospital of Philadelphia and Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA
11Division of Hematology and Oncology, Columbia University, New York, NY
12Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
13University of Milan, Milan, Italy
14National and Kapodistrian University of Athens, Athens, Greece
15Joan and Sanford I Weill Medical College of Cornell University, New York, NY
16Children’s Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
17Vertex Pharmaceuticals, Boston, MA
18CRISPR Therapeutics, Cambridge, MA
19Sarah Cannon Research Institute at The Children’s Hospital at TriStar Centennial, Nashville, TN

5:15 PM

Thomas J. Harrington, MD1, Adam Giermasz, MD, PhD2*, Nathan Visweshwar, MD3, Andrew D. Leavitt, MD4, Barbara A. Konkle, MD5,6, Jeremy Rupon, MD, PhD7, Gregory Dirusso, MD7, Li-Jung Tseng, PhD, MBA8*, Maria de los Angeles Resa, PhD9*, Florence Ganne10*, Delphine Agathon, PhD10*, Frank Plonski, MA, RN, BS7*, Didier Rouy, MD, PhD11*, Bettina M. Cockroft, MD, MBA11*, Annie F. Fang, MD, PhD9* and Steven Arkin, MD12

1Division of Hematology/Oncology, University of Miami Miller School of Medicine, Miami, FL
2University of California, Davis, Sacramento, CA
3University of South Florida, Tampa, FL
4University of California San Francisco, San Francisco, CA
5University of Washington, Seattle, WA
6Washington Center For Bleeding Disorders, Seattle, WA
7Pfizer Inc., Collegeville, PA
8Pfizer Inc., Peapack, NJ
9Pfizer Inc., New York, NY
10Pfizer Inc., Paris, France
11Sangamo Therapeutics, Brisbane, CA
12Rare Hematology Clinical Research, Pfizer Inc, Cambridge, MA

5:30 PM

Steven Pipe, MD1, Paul van der Valk, MD2*, Peter Verhamme3*, Peter Kampmann4*, Frank W.G. Leebeek, MD, PhD5, Michiel Coppens, MD6,7*, Karina Meijer, MD, PhD8*, Priyanka Raheja9*, Nigel S. Key, MD10, Nathan Visweshwar, MD11, Guy Young, MD12, Richard S. Lemons, MD, PhD13*, Robert Klamroth, MD14*, Wolfgang Miesbach, MD15*, Jan Astermark16,17, Niamh O'Connell18*, Rashid Saeed Kazmi, MBBS, FRCP, FRCPath19*, Nicholas Galante, PhD20*, Sandra LeQuellec, PhD20*, Paul Monahan20 and Cedric R. Hermans, MD, PhD21

1University of Michigan, Ann Arbor, MI
2Van Creveldkliniek, University Medical Center Utrecht, Utrecht, Netherlands
3University Hospitals Leuven, Belgium, Leuven, Belgium
4Rigshospitalet, Copenhagen, Denmark
5Department of Haematology, Erasmus University Medical Center-Erasmus MC, Rotterdam, Rotterdam, Netherlands
6Amsterdam University Medical Centers, Department of Vascular Medicine, University of Amsterdam, Amsterdam, Netherlands
7Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, Netherlands
8Department of Hematology, University Medical Center Groningen, Groningen, Groningen, Netherlands
9Royal London Haemophilia Centre, Bart health NHS trust, London, United Kingdom
10UNC Blood Reserach Center, Department of Medicine, University of North Carolina, Chapel Hill, NC
11University of South Florida, Tampa, FL
12Keck School of Medicine, University of Southern California, Los Angeles, CA
13University of Utah, Salt Lake City, UT
14Internal Medicine, Vascular Medicine and Coagulation Disorders, Vivantes Clinic Friedrichshain, Berlin, Germany
15Goethe University Hospital, Frankfurt, Germany
16Department of Hematology, Oncology and Radiation Physics, Skane University Hospital, Malmo, Sweden
17Department of Translational Medicine, Lund University, Malmö, Sweden
18National Coagulation Centre, St James’s Hospital, Dublin, Dublin, Ireland
19University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
20CSL Behring, King of Prussia, PA
21Cliniques Universitaires Saint-Luc, Brussels, BEL

5:45 PM

Ulrike M. Reiss, MD1, Andrew M. Davidoff, MD2, Edward G. D. Tuddenham, MD3,4*, Pratima Chowdary3,4*, Jenny H. McIntosh, PhD5*, Anne Riddell6*, Arnulfo Pie4*, Paul Batty, MBBS, PhD4,7*, Joanna C. M. Calvert4,8*, Sarah Mangles9*, Johnny Mahlangu, MBBCh, MMed10, Kristina M. Haley, DO11*, Michael Recht, MD, PhD, MBA12,13, Yu-Min Shen, MD14, Kathleen G. Halka, MD15, Junfang Zhou2*, Guolian Kang, PhD, MS16, Victoria Okhomina16*, Christopher L Morton17* and Amit C. Nathwani, MD, PhD18,19

1Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN
2Department of Surgery, St. Jude Children's Research Hospital, Memphis, TN
3UCL, London, United Kingdom
4Katharine Dormandy Haemophilia and Thrombosis Centre, Royal Free Hospital, London, United Kingdom
5Cancer Institute, University College London, London, United Kingdom
6Royal Free London NHS Foundation Trust, London, GBR
7Cancer Institute, University College, London, United Kingdom
8Cancer Institute, University College London (UCL, London, United Kingdom
9Hampshire Hospitals NHS Foundation Trust, Basingstoke, GBR
10University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
11Oregon Health Science University, Portland, OR
12American Thrombosis and Hemostasis Network, Rochester, CT
13Yale Center for Bleeding and Clotting Disorders, Yale University School of Medicine, New Haven, CT
14UT Southwestern Med. Ctr., Dallas, TX
15Texas A&M Health Science Center College of Medicine, Temple, TX
16Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN
17Department of Surgery, St Jude Children's Research Hospital, Memphis, TN
18Royal Free London - NHS Foundation Trust, London, United Kingdom
19Cancer Institute, UCL, London, ENG, United Kingdom

*signifies non-member of ASH